Information
Eugia US LLC Recalls Lidocaine HCl Injection
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0552-2026Drug / Pharmaceutical
Eugia US LLC Recalls Lidocaine HCl Injection
Eugia US LLC · Class III — Regulatory
Product Description
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Reason for Recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Eugia US LLC initiated a Class III recall of a pharmaceutical product on May 18, 2026 affecting 168,300 vials. Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan. Class III recalls involve products that are unlikely to cause adverse health reactions but violate FDA regulations. The product was distributed in US Nationwide. Consumers may continue monitoring FDA updates regarding this recall.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.